부산대학교 도서관

Purpose: To investigate potential risk factors, particularly antimetabolite choice, with regard to the development of adverse bleb morphology in eyes that had undergone trabeculectomy surgery. Methods: A single‐centre, observational cohort study of 631 consecutive eyes, which had undergone trabeculectomy over an 11‐year period. For each case, bleb morphology was recorded at 2 years, and its association with the per‐operative antimetabolite as well as potential confounding risk factors was analysed using univariate (unadjusted) and multivariate (adjusted) logistical regression analyses to identify those that could contribute to the development of adverse blebs. A standard protocol for 5‐fluorouracil and mitomycin‐C utilization was employed in the majority of cases. Results: When 5‐fluorouracil was used (n = 257), 24% of patients formed cystic or partially cystic blebs, whereas with mitomycin‐C (n = 299), only 12% formed such adverse blebs, the difference being statistically significant (OR = 3.54, p = 0.002 unadjusted; OR = 7.49, p = 0.00 adjusted). Of the other potential confounding factors, care within the private sector (OR = 0.30 p = 0.02) and a history of previous ocular surgery involving a conjunctival incision were identified as potential risk factors for the formation of adverse cystic blebs (OR = 0.28, p = 0.02). Conclusions: Modern use of mitomycin‐C appeared to be better than 5‐fluorouracil as an adjunctive antimetabolite used at the time of trabeculectomy, with respect to the development of preferable final bleb morphology. The only potential preoperative risk factors found to be significant with respect to adverse cystic bleb development were care in the private health sector and previous ocular surgery involving a conjunctival incision. [ABSTRACT FROM AUTHOR]